Slovenia, March 31 -- Slovenia based Med Gen-Sol Kft has secured contract from UNIVERZITETNI KLINICNI CENTER MARIBOR for Services provided by medical laboratories - Genomic testing for deciding on chemotherapy treatment in patients with early breast cancer for premenopausal patients and for patients suitable for the ADAPT protocol - repetition. The value of the contract is worth 14500000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....